Portal de investigación
CHAIMELEON. ACCELERATING THE LAB TO MARKET TRANSITION OF AI TOOLS FOR CANCER MANAGEMENT.
Datos básicos
- Código:
- 952172
- Protocolo:
- 952172
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 1.113.125,00 €
- Año de incio:
- 2020
- Año de finalización:
- 2025
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
"Near-TME": proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis.
Garcia-Granero, A.; (...); Garcia-Granero, E.
Article. 10.1007/s10151-022-02579-z. 2022
[ 177 Lu]Lu-DOTA-TATE and [ 131 I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.
Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco
Article. 10.3389/fendo.2022.778322. 2022
100% peer review in radiation oncology. Is it feasible?
Martin, E.; (...); Conde, A.
Meeting Abstract. 2020
100% Peer Review in Radiation Oncology. Is it feasible?
Martin Garcia, E.; (...); Tormo, A.
Meeting Abstract. 2021
177Lu-DOTATATE (PRRT) in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEPNETs) versus other tumors
Jimenez-Fonseca, P.; (...); Carmona-Bayonas, A.
Meeting Abstract. 2022
177-Lu-DOTATATE in 382 patients with somatostatin receptor-positive advanced tumors: Real-world data from the SEPTRALU registry
Casanovas M, Mitjavila; (...); Carmona-Bayonas, A.
Meeting Abstract. 2022
177Lu-DOTATATE in advanced neuroendocrine neoplasms of different locations - Data from 552 cases in the SEPTRALU registry
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2023
3D patient-specific spinal cord computational model for SCS management: potential clinical applications.
Solanes C; (...); Saiz J
Article. 10.1088/1741-2552/abe44f. 2021
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)
Gately L; (...); Balana C
Correction. 10.1007/s11060-024-04581-x. 2024
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately, L.; (...); Balana, C.
Article. 10.1007/s11060-023-04513-1. 2023
A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA
Gately, Lucy; (...); Balana, Carmen
Meeting Abstract. 2023
A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision
Giner, Francisco; (...); Garcia-Granero, Eduardo
Article. 10.1016/j.ciresp.2024.01.008. 2024
A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision.
Giner, Francisco; (...); Garcia-Granero, Eduardo
Article. 10.1016/j.cireng.2024.01.008. 2024
A Confidence Habitats Methodology in MR Quantitative Diffusion for the Classification of Neuroblastic Tumors.
Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis
Article. 10.3390/cancers12123858. 2020
A dosimetric index to assess cervix brachytherapy implants: Dovix
Chimeno, J; (...); Perez-Calatayud, J
Meeting Abstract. 2021
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
de la Fuente, Ana; (...); Ravassa, Susana
Article. 10.3390/cancers14122941. 2022
A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.
Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose
Article. 10.3390/ijms25042112. 2024
A Gadolinium(III) Complex Based on the Thymine Nucleobase with Properties Suitable for Magnetic Resonance Imaging
Orts-Arroyo, M; (...); Martinez-Lillo, J
Article. 10.3390/ijms22094586. 2021
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.
Okuno, Keisuke; (...); Goel, Ajay
Letter. 10.1186/s12943-022-01699-2. 2023
A Monte Carlo study of the relative biological effectiveness in surface brachytherapy.
Valdes-Cortez, Christian; (...); Vijande, Javier
Article. 10.1002/mp.15774. 2022
A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression.
Rades, Dirk; (...); Schild, Steven E.
Article. 10.1016/j.prro.2022.03.012. 2022
A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression
Rades, Dirk; (...); Schild, Steven E.
Article. 10.3390/cancers14153827. 2022
A phase Ib study of CC-90011, a potent, reversible, oral LSD1 inhibitor, plus etoposide and cisplatin (EP) or carboplatin (EC) in patients (Pts) with first-line (1L) extensive-stage (ES) small cell lung cancer (SCLC): Updated results
Ponce Aix, S.; (...); Paz-Ares, L.
Meeting Abstract. 2021
A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)
Llombart-Cussac, A; (...); Albanell, J
Meeting Abstract. 2021
A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).
Conde-Moreno, Antonio J; (...); Ferrer, Carlos
Article. 10.1016/j.prro.2024.04.022. 2024
A practical solution to estimate the sample size required for clinical prediction models generated from observational research on data
Baeza-Delgado, Carlos; (...); Marti-Bonmati, Luis
Article. 10.1186/s41747-022-00276-y. 2022
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24.
González-San Segundo C; (...); Couñago F
Article. 10.1111/bju.16484. 2024
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib.
Camidge DR; (...); Smit E
Article. 10.1016/j.cllc.2022.03.003. 2022
A rare case of diffuse and bilateral pulmonary uptake in 18 F-FDG PET/CT scan.
Olivan-Sasot, P; (...); Bello-Arques, P
Editorial Material. 10.1016/j.remn.2020.11.007. 2021
A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan.
Olivan-Sasot, P; (...); Bello-Arques, P
Article. 10.1016/j.remnie.2020.11.002. 2021
A single center, inter-observer evaluation of vestibular schwannoma stereotactic radiosurgery and its dosimetric impact
Perez-Calatayud, Maria Jose; (...); Perez-Calatayud, Jose
Article. 2024
A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.
Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.
Article. 10.1016/j.soncn.2023.151437. 2023
A system for mailed dosimetric audits of 192 Ir and 60 Co HDR brachytherapy combining OSLD and radiochromic film
Oliver-Canamas, Laura; (...); Perez-Calatayud, Jose
Article. 10.1016/j.radmeas.2024.107101. 2024
A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
Morarasu S; (...); Martin ST
Review. 10.1016/j.ejso.2021.05.011. 2021
A User-Friendly System for Mailed Dosimetric Audits of (192)Ir or (60)Co HDR Brachytherapy Sources.
Oliver-Canamas, Laura; (...); Perez-Calatayud, Jose
Article. 10.3390/cancers15092484. 2023
Absolute dose measurements using radiochromic films in 192Ir and 60Co HDR brachytherapy
Oliver Canamas, Laura; (...); Perez-Calatayud, Jose
Meeting Abstract. 2024
Accreditation of specialized surgical units in general and digestive surgery: A step forward by the AEC for quality improvement and subspecialized Fellowship training.
Millan M; (...); Serra-Aracil X
Article. 10.1016/j.cireng.2021.03.024. 2022
Accreditation of specialized surgical units in general and digestive surgery: A step forward by the AEC for quality improvement and subspecialized Fellowship training.
Millan M; (...); Serra-Aracil X
Article. 10.1016/j.ciresp.2021.03.001. 2022
Acute parotitis in high-dose-rate brachytherapy treatment for skin cancer: a case report.
Villalba SR; (...); Ortega MS
Article. 10.5114/jcb.2021.109994. 2021
Addressing the challenges of cancer care in older adults: The unique benefits of oncogeriatric evaluation and management.
Martinez-Peromingo, Javier; (...); Girones, Regina
Letter. 10.1016/j.regg.2023.03.002. 2023
Advances and controversies in management of breast ductal carcinoma in situ (DCIS).
Farante G; (...); Veronesi P
Article. 10.1016/j.ejso.2021.10.030. 2022
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting
Garrido Siles, Marga; (...); Angel Climent, Miguel
Review. 10.3390/cancers14163968. 2022
Alternatives of the pelvic sentinel lymph node migration pathway in early ovarian cancer: the simplest the best.
Lago, Victor; (...); Domingo, Santiago
Article. 10.1136/ijgc-2023-004912. 2023
Alveolar capillary dysplasia with misalignment of the pulmonary veins: A surgical lung biopsy and autopsy in a full-term newborn.
Rodríguez García C; (...); Mancheño Franch N
Article. 10.1016/j.patol.2024.06.005. 2024
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro, A; (...); Cho, B C
Article. 10.1016/j.annonc.2023.10.117. 2024
Amyloid brain-dedicated PET images can diagnose Alzheimer's pathology with Centiloid Scale.
Gandia-Ferrero MT; (...); Martí-Bonmatí L
Article. 10.1016/j.ejmp.2024.103345. 2024
An open-label, multicenter, phase 2 study of the safety and efficacy of navtemadlin (KRT-232) in patients with TP53 wild-type relapsed/refractory small cell lung cancer.
Dowlati, Afshin; (...); Carpeno, Javier de Castro
Meeting Abstract. 2022
ANALYSIS OF THE CLINICAL EXPERIENCE WITHIN RUCAPARIB'S EARLY ACCESS PROGRAM IN SPAIN - A GEICO STUDY
Yubero-Esteban, A.; (...); Gonzalez-Martin, A.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.398. 2021
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Tavira B; (...); González-Martín A
Article. 10.1158/1078-0432.CCR-23-0771. 2024
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.
Ruano-Ravina A; (...); Oramas J
Article. 10.21037/tlcr-21-559. 2021
Artificial intelligence and machine learning in cancer imaging.
Koh DM; (...); Prior F
Article. 10.1038/s43856-022-00199-0. 2022
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent, Joan; (...); Marti-Bonmati, Luis
Article. 10.1007/s10916-022-01836-w. 2022
Assessment of depth uncertainty and its influence on dose measurement in water phantoms
Chimeno, J.; (...); Perez-Calatayud, J.
Meeting Abstract. 2020
Association of Pelvic Organ Prolapse and Changes in Bone Imaging Biomarkers in Postmenopausal Women with Low Bone Mineral Density
Arguedas, Maria Perez; (...); Marti-Bonmati, Luis
Article. 10.31083/j.ceog5104092. 2024
Atezolizumab (atezo) combined with platinum-based chemotherapy (CT) and maintenance niraparib for recurrent ovarian cancer (rOC) with a platinum-free interval (TFIp) >6 months: Primary analysis of the double-blind placebo (pbo)controlled ENGOT-Ov41/GEICO 69-O/ANITA phase III trial
Martin, A. Gonzalez; (...); Selle, F.
Meeting Abstract. 10.1016/j.annonc.2023.10.031. 2023
Automated Cervical Spinal Cord Segmentation in Real-World MRI of Multiple Sclerosis Patients by Optimized Hybrid Residual Attention-Aware Convolutional Neural Networks
Bueno, America; (...); Alberich-Bayarri, Angel
Article. 10.1007/s10278-022-00637-4. 2022
Automated prostate multi-regional segmentation in magnetic resonance using fully convolutional neural networks
Jimenez-Pastor, Ana; (...); Alberich-Bayarri, Angel
Article. 10.1007/s00330-023-09410-9. 2023
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Automatic magnetic resonance imaging series labelling for large repositories
Gomis-Maya, Armando; (...); Marti-Bonmati, Luis
Article. 10.1186/s40537-025-01086-w. 2025
Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy
Chimeno, J; (...); Perez-Calatayud, J
Meeting Abstract. 2021
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC.
Andric, Zoran; (...); Ciardiello, Fortunato
Article. 10.1016/j.jtocrr.2022.100461. 2023
Baseline circulating myeloid-derived suppressor cells correlate with neutrophil-to-lymphocyte ratio and overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Garcia-Sanchez, J.; (...); Lahoz, A.
Meeting Abstract. 2021
Biological significance of cribriform pattern in radical prostatectomy specimens: Study of its prognostic significance in biochemical recurrence
Gomez, PF; (...); Boronat, TF
Meeting Abstract. 2021
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Botulinum Toxin Injection Plus Topical Diltiazem for Chronic Anal Fissure: A Randomized Double-Blind Clinical Trial and Long-term Outcome.
Herreros, B; (...); Minguez, M
Article. 10.1097/DCR.0000000000001983. 2021
Brain network functional connectivity changes in patients with anterior knee pain: a resting-state fMRI exploratory study.
Sanchis-Alfonso, Vicente; (...); Marti-Bonmati, Luis
Article. 10.1186/s41747-023-00378-1. 2023
Bridging gaps between images and data: a systematic update on imaging biobanks.
Gabelloni, Michela; (...); Neri, Emanuele
Article. 10.1007/s00330-021-08431-6. 2022
Calibration and validation of a bleeding detector for beveled PMMA applicators in electron intraoperative radiotherapy
Garcia-Gil, Rafael; (...); Sanchis-Sanchez, Enrique
Article. 10.1088/1361-6501/ad48a6. 2024
Capmatinib vs docetaxel as second- or third-line (2/3L) therapy in patients (pts) with METex14-mutated advanced NSCLC (aNSCLC): The GeoMETry-III trial
Vidal, O. J. Juan; (...); Wolf, J.
Meeting Abstract. 10.1016/j.annonc.2023.09.2424. 2023
Cardiorespiratory coupling in cetaceans; a physiological strategy to improve gas exchange?
Fahlman A; (...); Blawas A
Article. 10.1242/jeb.226365. 2020
Ciliary body medulloepithelioma treated with intra-operative brachytherapy after fine needle aspiration biopsy
Ortiz-Seller, Amparo; (...); Gonzalez, Honorio Barranco
Article. 10.5114/jcb.2022.116926. 2022
Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
Herranz, R; (...); Medina, P
Review. 10.3390/cancers13061448. 2021
Clinical and cost outcomes of a polyethylene glycol (PEG)-coated patch versus drainage after axillary lymph node dissection in breast cancer: results from a multicentre randomized clinical trial.
Buch-Villa E; (...); Ortega J
Article. 10.1093/bjs/znad150. 2023
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
Perez-Fidalgo, Jose Alejandro; (...); Gonzalez-Martin, Antonio
Article. 10.1136/ijgc-2022-004028. 2023
Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)
Franco, FF; (...); Provencio, M
Meeting Abstract. 10.1016/j.annonc.2021.08.1771. 2021
Clinical experience of whole body and tumour dosimetry of 131-I-mIBG treatment for pediatric patients
Espallardo, I. Torres; (...); Prado-Wohlwend, S.
Meeting Abstract. 2023
Clinical experience with rucaparib after prior PARPi treatment: A subanalysis from the rucaparib access program in Spain by GEICO.
Yubero-Esteban, Alfonso; (...); Sanchez Lorenzo, Maria Luisa
Meeting Abstract. 2022
Clinical insights from the rucaparib access program in Spain: A sub-analysis of long-term responders by GEICO.
Yubero-Esteban, Alfonso; (...); Gonzalez Martin, Antonio
Meeting Abstract. 2022
Cold loop polypectomy perforation of a tiny colon polyp.
Mínguez Sabater A; (...); Bustamante-Balén M
Article. 10.17235/reed.2021.8221/2021. 2021
ComBat harmonization in different PET imaging scenarios
Gandia-Ferrero, M.; (...); Marti-Bonmati, L.
Meeting Abstract. 2023
Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images
Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis
Article. 10.3390/cancers14153648. 2022
Comparison of 3D dosimetry methods in hepatic radioembolisation with Y-90 microspheres
Carrasco Vela, N.; (...); Torres-Espallardo, I.
Meeting Abstract. 2021
Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials
Rades, D; (...); Schild, SE
Article. 10.1186/s13014-020-01737-7. 2021
Comparison of protocols with respiratory-gated (4D) motion compensation in PET/CT: open-source package for quantification of phantom image quality.
Martinez-Movilla, Andrea; (...); Carles, Montserrat
Article. 10.1186/s40658-022-00509-4. 2022
Comparison of vertical and extended vertical rectus abdominis myocutaneous flaps. An anatomical study.
Perez-Garcia, Alberto; (...); Garcia-Granero, Eduardo
Article. 10.1080/2000656X.2021.2024554. 2022
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: Results of the RING observational trial.
Romero A; (...); Provencio M
Article. 10.1002/1878-0261.12832. 2020
Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Valladares-Ayerbes, M; (...); Vila, AL
Meeting Abstract. 10.1016/j.annonc.2021.08.976. 2021
Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.
Samper Ots PM; (...); Villafranca Iturre E
Article. 10.1007/s12094-020-02510-8. 2021
Considerations for artificial intelligence clinical impact in oncologic imaging: an AI4HI position paper
Marti-Bonmati L; (...); Tsakou G
Article. 10.1186/s13244-022-01220-9. 2022
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
García-Campelo R; (...); Dómine M
Correction. 10.1007/s12094-023-03290-7. 2023
Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13 , 2980.
Pardo-Sanchez, Jose Miguel; (...); Farràs R
Article. 10.3390/cancers13194825. 2021
Correction: Update on the management of elderly patients with colorectal cancer.
Soler-González G; (...); Gironés-Sarrió R
Correction. 10.1007/s12094-023-03351-x. 2024
Correlation Between Clinical Characteristics And Effective Washout Time In Patients Treated With High Radioiodine Activities
Guerrero Calatayud, C.; (...); Bello Arques, P.
Meeting Abstract. 2023
Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
Reck, M.; (...); John, T.
Correction. 10.1016/j.esmoop.2021.100345. 2021
COVID-19 and hospitalised cancer patients: Now it's time for patients to talk
Arrue, BD; (...); Sarrio, RG
Meeting Abstract. 10.1016/j.annonc.2020.08.2061. 2020
Current treatment landscape for oligometastatic non-small cell lung cancer
Garde-Noguera, Javier; (...); Counago, Felipe
Article. 10.5306/wjco.v13.i6.485. 2022
CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.
Sanchis-Pascual, David; (...); Merino-Torres, Juan Francisco
Article. 10.3390/cancers16101799. 2024
Cyclin E cytoplasmatic isoform to predict outcome and benefit to capecitabine treatment in patients with HR+/HER2-metastatic breast cancer from the GEICAM/2013-02 PEARL study
Guerrero, Angel; (...); Martin, Miguel
Meeting Abstract. 2023
CHAIMELEON Project: Creation of a Pan-European Repository of Health Imaging Data for the Development of AI-Powered Cancer Management Tools.
Bonmati, Luis Marti; (...); Alberich-Bayarri, Angel
Article. 10.3389/fonc.2022.742701. 2022
Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clinical practice (SILK study)
Aransay, N. Reguart; (...); Vila, A. Lloansi
Meeting Abstract. 10.1016/j.annonc.2023.09.2442. 2023
Characterization of Plastic Scintillator Detector for In Vivo Dosimetry in Gynecologic Brachytherapy.
Herreros A; (...); Rovirosa A
Article. 10.3390/jpm14030321. 2024
Characterization of the gene expression profile of breast cancer tumours in patients undergoing ovarian stimulation for fertility preservation purposes
Soriano, M. J.; (...); Diaz-Garcia, C.
Meeting Abstract. 2022
D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis.
Balciscueta, Zutoia; (...); Garcia-Granero, Alvaro
Article. 10.1016/j.ejso.2021.02.020. 2021
Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions
Nan, Yang; (...); Yang, Guang
Review. 10.1016/j.inffus.2022.01.001. 2022
Data infrastructures for AI in medical imaging: a report on the experiences of five EU projects
Kondylakis, Haridimos; (...); Lekadir, Karim
Article. 10.1186/s41747-023-00336-x. 2023
Deep learning automatic semantic segmentation of glioblastoma multiforme regions on multimodal magnetic resonance images.
Beser-Robles, Maria; (...); Marti-Bonmati, Luis
Article. 10.1007/s11548-024-03205-z. 2024
Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients
Sarrio, RG; (...); Porta-Sales, J
Article. 10.1186/s12904-020-00693-z. 2021
Description of the clinical characteristics and survival in patients with metastatic NSCLC in the Spanish population: An analysis of the thoracic tumours registry (RTT study)
Franco, F; (...); Pulla, MP
Meeting Abstract. 10.1016/j.annonc.2020.08.1694. 2020
Design and validation of a decision support checklist for efficient resource allocation in research projects during proposal preparation.
Penades-Blasco, Ana; (...); Marti-Bonmati, Luis
Article. 10.1016/j.ejrad.2024.111362. 2024
Determination of essential biomarkers in lung cancer: A real-world data study in Spain
Calvo de Juan, V.; (...); Provencio Pulla, M.
Meeting Abstract. 10.1016/j.annonc.2022.02.048. 2022
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
Provencio, Mariano; (...); Torrente, Maria
Article. 10.1186/s12885-022-09830-8. 2022
Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation.
Carles, Montserrat; (...); Gkika, Eleni
Article. 10.1007/s00330-024-10751-2. 2024
Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer
Feliu, J; (...); Molina-Garrido, MJ
Article. 10.3390/jcm10081615. 2021
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/liv.15766. 2024
Development of a predictive model for early detection of lung cancer: SREAL-eLUNG study
Vidal, O. J. Juan; (...); Martinez, B. Valdivieso
Meeting Abstract. 2023
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
Munoz, Andres J.; (...); Hernandez-Presa, Miguel Angel
Article. 10.1016/j.thromres.2023.06.015. 2023
Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray
Calvillo-Batllés P; (...); Martí-Bonmatí L
Article. 10.1016/j.rx.2021.09.011. 2022
Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.
Calvillo-Batllés P; (...); Martí-Bonmatí L
Article. 10.1016/j.rxeng.2021.09.004. 2022
Diagnostic accuracy of C-reactive protein, procalcitonin and neutrophils for the early detection of anastomotic leakage after colorectal resection: a multicentric, prospective study
Sala Hernandez, Angela; (...); Garcia-Granero, Eduardo
Article. 10.1111/codi.15845. 2021
DICOM-MIABIS integration model for biobanks: a use case of the EU PRIMAGE project
Scapicchio C; (...); Neri E
Article. 10.1186/s41747-021-00214-4. 2021
Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients
Marti-Aguado, D; (...); Marti-Bonmati, L
Article. 10.1016/j.crad.2020.07.031. 2020
Differences in technical and clinical perspectives on AI validation in cancer imaging: mind the gap!
Chouvarda, Ioanna; (...); Papanikolaou, Nikolaos
Article. 10.1186/s41747-024-00543-0. 2025
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/apt.16100. 2021
Do SPECT CT and sentinel node tecnhique increase the diagnosis of metastasic disease in prostate cancer?
Perez Ardavin, J.; (...); Vera-Donoso, C. D.
Meeting Abstract. 2022
Documenting the de-identification process of clinical and imaging data for AI for health imaging projects
Kondylakis, Haridimos; (...); Tsiknakis, Manolis
Article. 10.1186/s13244-024-01711-x. 2024
Durvalumab (D) plus tremelimumab (T) in platinum-refractory/resistant extensive-stage small cell lung cancer (ES-SCLC): Efficacy, safety and ctDNA dynamics from Arm A of the phase 2 BALTIC study
Reinmuth, Niels; (...); Bondarenko, Igor
Meeting Abstract. 2022
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Contreras-Toledo, Debora; (...); Carmona-Bayonas, Alberto
Article. 10.1038/s41416-023-02563-w. 2024
Early colorectal cancer diagnosed after endoscopic resection: Conservative treatment is safe in most of the cases. Proposal for a risk-based management.
Sancho-Muriel J; (...); Frasson M
Article. 10.1016/j.ciresp.2021.04.019. 2021
Early colorectal cancer diagnosed after endoscopic resection: Conservative treatment is safe in most of the cases. Proposal for a risk-based management.
Sancho-Muriel J; (...); Frasson M
Article. 10.1016/j.cireng.2022.08.018. 2022
ECONOMIC BURDEN OF ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS HARBORING KRASG12C MUTATION IN SPAIN
Fernandez-Barcelo, C.; (...); Sampietro-Colom, L.
Meeting Abstract. 2023
ECONOMIC IMPACT OF THE NSCLC MOLECULAR DIAGNOSIS IN SPAIN: A RETROSPECTIVE ANALYSIS OF HEALTHCARE RESOURCES USE AND ASSOCIATED COSTS FROM THE LUNG-ONE STUDY
de Castro, J; (...); Rojo, F
Meeting Abstract. 2020
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
Effects of 3 Tesla magnetic resonance imaging exposure on the behavior and orientation of homing pigeons Columba livia domestica.
Parraga, Daniel Garcia; (...); Marti-Bonmati, Luis
Article. 10.1371/journal.pone.0241280. 2020
Efficacy and clinical and neuroimaging biomarkers of response of two intensive and spaced treatment protocols of theta burst magnetic stimulation in treatment resistant depression
Canada, Y.; (...); Sierra, P.
Meeting Abstract. 10.1192/j.eurpsy.2023.1269. 2023
Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2023
Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations (METex14).
Brandao, Mariana da Rocha Almeida; (...); Felip, Enriqueta
Meeting Abstract. 2024
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Mitjavila, Mercedes; (...); Carmona-Bayonas, Alberto
Article. 10.1007/s00259-023-06166-8. 2023
Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.
Angeles Vaz, Maria; (...); De Las Penas Bataller, Ramon
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14046. 2021
Electronic Design for a Bleeding Detector to be Used in Intraoperative Radiotherapy Applications
Garcia-Gil, R; (...); Peris, ES
Article. 10.1109/JSEN.2020.3032828. 2021
Embedded bleeding detector into a PMMA applicator for electron intraoperative radiotherapy.
Garcia-Gil, Rafael; (...); Sanchis, Enrique
Article. 10.1016/j.ejmp.2021.12.018. 2022
Embracing critical thinking to enhance our practice
Editorial Material. 10.1186/s13244-023-01435-4. 2023
Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure
Marti-Bonmati, Luis; (...); EUCAIM Consortium European Soc Radiology, Hanna
Article. 10.1186/s13244-025-01913-x. 2025
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).
Marquez-Rodas, Ivan; (...); Berrocal, Alfonso
Article. 10.1093/neuonc/noae116. 2024
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; (...); Ramos Soler D
Article. 10.3791/65635. 2023
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry
Franco, F; (...); Provencio, M
Article. 10.1371/journal.pone.0251761. 2021
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
Loras, A, Segovia, C, Ruiz-Cerda, JL
Review. 10.3390/cancers13112719. 2021
European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.
Boormans, Joost; (...); Laguna, Pilar
Meeting Abstract. 2023
European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient.
Suay, Guillermo, Aparisi, Francisco, Juan-Vidal, Oscar
Article. 10.21037/cco-23-100. 2024
Evaluation of 177Lu-DOTATATE treatment in patients with metastasic or unresectable paragangliomas and pheochromocytomas
Canon Sanchez, J.; (...); Utrera Costero, A.
Meeting Abstract. 2021
Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for I-125 prostate implants
Assam, Isong; (...); Siebert, Frank-Andre
Article. 10.1002/mp.15865. 2022
Evaluation of EMBARK criteria patients. Real-world data on prostate cancer biochemical recurrence
Centelles Hidalgo, Elena; (...); Lopez-Campos, Fernando
Meeting Abstract. 2024
Evaluation of intrafraction motion with an open immobilization mask for HyperArc treatment of multiple brain metastases
Tejedor-Aguilar, Natalia; (...); Perez-Calatayud, Jose
Article. 2023
Evaluation of intrafraction motion with an open immobilization mask for HyperArc treatment of multiple brain metastases.
Tejedor-Aguilar, Natalia; (...); Perez-Calatayud, Jose
Article. 2022
Evaluation of pneumatosis intestinalis as a complication of lung transplantation
Ripolles, V. Belloch; (...); Marti-Bonmati, Y. L.
Article. 10.1016/j.rx.2023.01.006. 2024
Evaluation of pneumatosis intestinalis as a complication of lung transplantation.
Belloch Ripollés V; (...); Martí-Bonmatí L
Article. 10.1016/j.rxeng.2023.01.013. 2024
Evaluation of the impact of EMBRACE II protocol in Spanish centers, with a large cohort of patients using a ranking index.
Chimeno J; (...); Pérez-Calatayud J
Article. 10.5114/jcb.2021.112119. 2021
Evaluation of the optical criteria for sessile serrated lesions of the colon: A prospective study on a colorectal cancer screening population.
Bustamante-Balen, Marco; (...); Pons-Beltran, Vicente
Article. 10.1055/a-1293-7086. 2021
Evidence levels in radiology: the insights into imaging approach.
Editorial Material. 10.1186/s13244-021-00995-7. 2021
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.
Valladares-Ayerbes M; (...); Lloansí Vila A
Article. 10.3390/cancers14246075. 2022
Evolving Characteristics of Gadolinium-Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity.
Kanal, Emanuel; (...); Marti-Bonmati, Luis
Article. 10.1002/jmri.29367. 2024
Executive dysfunction and cortical variations among intimate partner violence perpetrators and the association with sexism.
Romero-Martinez, Angel; (...); Moya-Albiol, Luis
Article. 10.1093/scan/nsae046. 2024
Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma
Villar, MV; (...); Santos, JD
Meeting Abstract. 10.1016/j.annonc.2021.08.008. 2021
Experimental phantom evaluation to identify robust positron emission tomography (PET) radiomic features
Carles, Montserrat; (...); Mix, Michael
Article. 10.1186/s40658-021-00390-7. 2021
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.
Arriola E; (...); Felip E
Article. 10.1007/s40261-024-01379-7. 2024
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.
Nadal E; (...); Gironés R
Article. 10.1007/s12094-023-03286-3. 2023
Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer.
Torregrosa-Maicas MD; (...); Gironés-Sarrió R
Article. 10.1007/s12094-021-02766-8. 2022
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; (...); Balana C
Article. 10.1007/s11060-024-04668-5. 2024
Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group
Cao, MG; (...); Costa, RR
Meeting Abstract. 10.1016/j.annonc.2020.08.1589. 2020
Extended right hemicolectomy with central ligation of the middle colic vessels - video vignette.
Cholewa H; (...); Sancho-Muriel J
Article. 10.1111/codi.15747. 2021
Extended vertical rectus abdominis myocutaneous flap for reconstruction of large pelviperineal defects following oncologic resection
Perez-Garcia, Alberto; (...); Garcia-Granero, E.
Article. 10.1002/jso.27068. 2022
Extensive stage (ES) small-cell lung cancer (SCLC) in Spain: A review of demographic, epidemiological and clinical data from the Thoracic Tumors Registry (TTR study)
Calvo, V; (...); Pulla, MP
Meeting Abstract. 10.1016/j.annonc.2020.08.1555. 2020
F-18-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
Carles, M; (...); Nicolay, NH
Article. 10.3390/cancers13143449. 2021
Factors Associated With Increased Complications in Patients With BRCA Gene Mutations Undergoing Reconstructive Breast Surgery.
Vanaclocha N; (...); Sánchez García A
Article. 10.1097/PSN.0000000000000331. 2021
FAMetA: a mass isotopologue-based tool for the comprehensive analysis of fatty acid metabolism.
Alcoriza-Balaguer MI; (...); Lahoz A
Article. 10.1093/bib/bbad064. 2023
Family History of Cancer and Lung Cancer: Information from the Thoracic Tumors Registry (TTR Study)
Calvo, V.; (...); Provencio, M.
Meeting Abstract. 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy.
Carles M; (...); Gkika E
Article. 10.3390/cancers13040814. 2021
Feasibility and outcomes of transjugular intrahepatic portosystemic shunts in infants.
Martinez-Rodrigo, Jose J.; (...); Marti-Bonmati, Luis
Article. 10.1007/s00247-022-05575-5. 2022
Feasibility and potential advantages using VMAT in SRS metastasis treatments
Jose Perez-Calatayud, Maria; (...); Perez-Calatayud J
Article. 10.5603/RPOR.a2021.0019. 2021
Feasibility in using a nomogram as an independent verification process in HDR prostate brachytherapy
Denia, PM; (...); Perez-Calatayud, J
Meeting Abstract. 2021
Final database lock results of the phase 2 cohort of lenvatinib plus pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
Lee, Chung-Han; (...); Motzer, Robert J.
Meeting Abstract. 2023
First Spanish consensus on the use of intraoperative radiotherapy in breast cancer. Conclusions of the expert panel
Eraso, Arantxa; (...); Algara, Manuel
Review. 10.1016/j.senol.2023.100502. 2023
First-line (1L) nivolumab (N) plus ipilimumab (I) plus chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes by tumor histologic subtype (THS)
Carbone, David Paul; (...); Reck, Martin
Meeting Abstract. 2023
First-line (1L) nivolumab (N) plus ipilimumab (I) plus chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes by tumor histologic subtype (THS).
Carbone, David Paul; (...); Reck, Martin
Meeting Abstract. 10.1200/JCO.2023.41.17_suppl.LBA9023. 2023
First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
Andric, Z. G.; (...); Ciardiello, F.
Meeting Abstract. 2021
First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort
Oliveres, H.; (...); Maurel, J.
Meeting Abstract. 10.1016/j.annonc.2023.09.1796. 2023
First-line Nivolumab (N) plus Ipilimumab (I) plus Chemotherapy (C) in Metastatic NSCLC (mNSCLC): CheckMate 9LA 4-Year Clinical Update
Baclin, Firas; (...); Reck, Martin
Meeting Abstract. 2024
First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA.
Reck, Martin; (...); John, Tom
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.9000. 2021
First-line nivolumab (NIVO) plus ipilimumab (IPI)+2 cycles chemotherapy (chemo) vs 4 cycles chemo in advanced non-small cell lung cancer (aNSCLC): Association of blood and tissue tumor mutational burden (TMB) with efficacy in CheckMate 9LA
Paz-Ares, L.; (...); Carbone, D. P.
Meeting Abstract. 2021
First-line nivolumab (NIVO) plus ipilimumab (IPI)+2 cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): 2-year update from CheckMate 9LA
Reinmuth, N.; (...); John, T.
Meeting Abstract. 2021
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Paz-Ares, Luis; (...); Reck, Martin
Article. 10.1016/S1470-2045(20)30641-0. 2021
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Ready, Neal E.; (...); Paz-Ares, Luis
Article. 10.1136/jitc-2022-006127. 2023
First-line Nivolumab plus Ipilimumab plus Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA
Carbone, D.; (...); Lu, S.
Meeting Abstract. 2021
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
Paz-Ares, Luis G.; (...); Carbone, David P.
Article. 10.1016/j.jtho.2022.10.014. 2023
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
Reck M; (...); John T
Article. 10.1016/j.esmoop.2021.100273. 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.
Reck, Martin; (...); Carbone, David P.
Article. 10.1016/j.ejca.2023.01.015. 2023
Five-year outcomes with first-line (1L) nivolumab plus ipilimumab plus chemotherapy (N plus I plus C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA.
Reck, Martin; (...); Paz-Ares, Luis G.
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.8560. 2024
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial.
Reck M; (...); Paz-Ares LG
Article. 10.1016/j.ejca.2024.114296. 2024
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP; (...); Reck M
Article. 10.1136/jitc-2023-008189. 2024
Free automatic software for quality assurance of computed tomography calibration, edges and radiomics metrics reproducibility.
Saborido-Moral, Juan D.; (...); Carles, Montserrat
Article. 10.1016/j.ejmp.2023.103153. 2023
FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations (FURMO-002)
Le, Xiuning; (...); Wang, Jie
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.TPS8666. 2024
GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non-small cell lung cancer (NSCLC)-A randomized, double-blind trial.
Ghiringhelli, Francois; (...); Basse, Linda
Meeting Abstract. 2022
GEC-ESTRO recommendations for commissioning a brachytherapy TPS
De Brabandere, M.; (...); Siebert, F.
Meeting Abstract. 2023
GEC-ESTRO Recommendations on Calibration and Traceability of HE HDR-PDR Photon Brachytherapy Sources
Perez Calatayud, J.; (...); Vijande, J.
Meeting Abstract. 2023
GEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
Fidalgo, JAP; (...); Martin, AG
Meeting Abstract. 10.1016/j.annonc.2020.08.971. 2020
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
Elez E; (...); Garrido P
Article. 10.1016/j.esmoop.2021.100048. 2021
Genotypic Characteristics and Resistance Mutations in Advanced ALK plus NSCLC: The ALK-PATHFINDER Study
Lopez Castro, R.; (...); Ponce Aix, S.
Meeting Abstract. 2023
Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
Vaz, M. A.; (...); Girones, R.
Meeting Abstract. 10.1016/j.annonc.2023.09.1695. 2023
Gradient-based alternative to Lattice radiotherapy for the treatment of bulky tumours
Guevara Barrera, Diana; (...); Santos Ortega, Manuel
Meeting Abstract. 2024
Gray matter volume differences in intimate partner violence perpetrators and its role in explaining dropout and recidivism
Romero-Martinez, Angel; (...); Moya-Albiol, Luis
Article. 10.1016/j.jpsychires.2024.09.019. 2024
Guideline development GEC ESTRO
Strnad, V., Perez-Calatayud, J., Jurgenliemk-Schulz, I.
Meeting Abstract. 2021
HDR brachytherapy in keratinocyte skin carcinomas - Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicity.
Rodriguez Villalba, Silvia; (...); Rembielak, Agata
Article. 10.1016/j.brachy.2022.10.003. 2022
Health-related quality of life (QoL) in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD), a multicenter single-arm phase II clinical trial (ROLANDO, GEICO-1601).
Alejandro Perez-Fidalgo, Jose; (...); Gonzalez-Martin, Antonio
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.5549. 2021
Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging
Perez-Girbes, A., Lee, J. M., Marti-Bonmati, L.
Article. 10.1016/j.rx.2024.05.004. 2024
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1.
Muñoz-Unceta N; (...); Grupo de trombosis y cáncer SEOM
Article. 10.1016/j.ejca.2020.10.002. 2020
Higher-dose radiotherapy for metastatic spinal cord compression: First results of a phase II trial
Rades, D.; (...); Cacicedo, J.
Meeting Abstract. 2021
How to Know if a D3 Lymphadenectomy Has Been Actually Performed in a Right Hemicolectomy: Focus on the Pathology Report.
Alfonso-Garcia, Maria; (...); Garcia-Granero, Eduardo
Article. 10.1097/DCR.0000000000002175. 2021
Hybrid 3DRT-VMAT technique in the treatment planning of hypofractionated whole-breast radiotherapy
Guevara Barrera, Diana; (...); Santos Ortega, Manuel
Meeting Abstract. 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Rodríguez-Lescure Á; (...); de la Haba-Rodriguez J
Article. 10.1007/s12094-024-03411-w. 2024
I-131-MIBG treatment in patients with metastatic paraganglioma and pheocrhomocytoma
Bernal, J; (...); Bello, P
Meeting Abstract. 2020
IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1016/j.cgh.2024.10.014. 2024
Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
Article. 10.3390/ijms22157913. 2021
Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
Article. 10.3390/biomedicines8110447. 2020
Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project.
Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis
Article. 10.1007/s00247-023-05770-y. 2023
Imaging Biomarkers in Amyotrophic Lateral Sclerosis
Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis
Editorial Material. 10.1007/978-1-0716-1712-0_20. 2022
Imaging features and clinical data-based network analysis of CAR-T treated B- cell lymphoma patients in relation to their TP53 mutation status
Estepa-Fernandez, A.; (...); Alberich-Bayarri, A.
Meeting Abstract. 2024
Immunogenicity of COVID-19 vaccines in lung cancer patients.
Provencio M; (...); Calvo V
Article. 10.1016/j.lungcan.2023.107323. 2023
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.1016/j.ejca.2020.08.020. 2020
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.
Lopez-Campos, Fernando; (...); Couñago F
Article. 10.3390/biomedicines10030537. 2022
Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial
Guckenberger, M; (...); Stahel, RA
Meeting Abstract. 10.1016/j.annonc.2020.08.1731. 2020
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study.
Rondan, Maria Arnal; (...); Sarrio, Regina Girones
Article. 10.1007/s12094-024-03657-4. 2024
Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain
Gomez-Palomo, F.; (...); Ruiz Cerda, J. L.
Article. 10.1016/j.acuro.2021.10.001. 2022
Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain.
Gomez-Palomo, F; (...); Ruiz Cerda, J L
Article. 10.1016/j.acuroe.2021.10.004. 2022
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/cancers15061705. 2023
Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.
Vaz Salgado, Maria Angeles; (...); De Las Penas Bataller, Ramon
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14047. 2021
Importance of some technical aspects of the procedure of percutaneous posterior tibial nerve stimulation in patients with fecal incontinence.
Rodriguez Carrillo, Rodolfo; (...); Garcia-Granero Ximenez, Eduardo
Article. 10.1016/j.ciresp.2020.08.008. 2021
Importance of some technical aspects of the procedure of percutaneous posterior tibial nerve stimulation in patients with fecal incontinence.
Rodríguez Carrillo R; (...); García-Granero Ximénez E
Article. 10.1016/j.cireng.2021.07.010. 2021
In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study
Herreros, Antonio; (...); Rovirosa, Angeles
Article. 10.3390/jpm12060911. 2022
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
García-Ortega A; (...); Martínez-García MÁ
Article. 10.1016/j.jinf.2021.01.003. 2021
Increased femoral anteversion in females with anterior knee pain relates to both the neck and the shaft of the femur.
Sanchis-Alfonso V; (...); Doménech-Fernández J
Article. 10.1007/s00402-023-05036-0. 2023
Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation
Pardo-Sanchez, JM; (...); Farras, R
Article. 10.3390/cancers13122980. 2021
Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images
Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis
Article. 10.3390/cancers15051622. 2023
Insights into my experience as the Editor-in-Chief: a recap to close an unforgettable chapter.
Editorial Material. 10.1186/s13244-024-01878-3. 2024
Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments
Perez Calatayud, M. J.; (...); Tormo, A.
Meeting Abstract. 2020
Interventional solutions for post-surgical problems: a lymphatic leaks review
Gomez, Fernando M.; (...); Bonmati, Luis Marti
Review. 10.1186/s42155-024-00473-3. 2024
Interventional solutions for post-surgical problems: a lymphatic leaks review (vol 7, 61, 2024)
Gomez, Fernando M.; (...); Bonmati, Luis Marti
Correction. 10.1186/s42155-024-00483-1. 2024
Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
Marquez-Rodas, I; (...); Berrocal, A
Meeting Abstract. 10.1016/j.annonc.2021.08.1423. 2021
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets.
Coronado, Esther; (...); Font de Mora, Jaime
Article. 10.1002/1878-0261.12868. 2021
Intravenous SPION-labeled adipocyte-derived stem cells targeted to the brain by magnetic attraction in a rat stroke model: An ultrastructural insight into cell fate within the brain.
García-Belda P; (...); Gil-Perotín S
Article. 10.1016/j.nano.2021.102464. 2021
Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; (...); Pemán J
Case Reports. 10.1016/j.riam.2021.06.002. 2021
Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
Bellver G; (...); Ortega J
Article. 10.1016/j.jss.2021.10.006. 2022
Is Body Appreciation a Moderator of Women's Satisfaction and Distress with the Body Changes that Occur after Breast Cancer Surgery? A One-Year Longitudinal Study.
Marco-Salvador JH; (...); Ripoll Orts F
Article. 10.1017/SJP.2024.13. 2024
Knee Cartilage and Subchondral Bone Evaluations by Magnetic Resonance Imaging Correlate with Histological Biomarkers in an Osteoarthritis Rabbit Model
Sifre V; (...); Martí-Bonmatí L
Article. 10.1177/19476035221118166. 2022
KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
Mok, Tony S. K.; (...); Barlesi, Fabrice
Meeting Abstract. 10.1200/JCO.2024.42.17_suppl.LBA8509. 2024
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Bekki, Amina; (...); Angel Martinez-Garcia, Miguel
Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.
Mizutani, Tomonori; (...); Kanesvaran, Ravindran
Article. 10.1016/j.jgo.2024.101709. 2024
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee, Chung-Han; (...); Motzer, Robert J
Letter. 10.1016/j.eururo.2024.05.003. 2024
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Lee, CH; (...); Motzer, JR
Article. 10.1016/S1470-2045(21)00241-2. 2021
Less is more: Usefulness of the sentinel node technique in radical prostatectomy
Perez Ardavin, J.; (...); Vera-Donoso, C. D.
Meeting Abstract. 2022
Let's Take Care Of Our Future
Serra-Aracil, X; (...); Garcia-Granero, E
Editorial Material. 10.1016/j.ciresp.2020.04.014. 2020
LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Liposomal Irinotecan in Adults with Small Cell Lung Cancer who Progressed on Platinum-Based Therapy: Subgroup Analyses by Platinum Sensitivity
Spigel, DR; (...); Bunn, P
Meeting Abstract. 2021
Local salvage brachytherapy for recurrent prostate cancer: a mono- institutional experience
Rodriguez Villalba, Silvia; (...); Santos Ortega, Manuel
Meeting Abstract. 2024
Long-term oncological outcome of segmental versus extended colectomy for colorectal cancer in Crohn's disease: results from an international multicentre study.
Sensi B; (...); Sica GS
Article. 10.1093/ecco-jcc/jjab215. 2022
Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study (vol 15, pg 874, 2021)
Sensi B; (...); Sica GS
Article. 10.1093/ecco-jcc/jjac022. 2022
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Alamo IV registry.
Martin, Miguel; (...); Aguiar-Bujanda, David
Article. 10.1007/s10549-023-07002-1. 2023
Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: long-term results from a single institution team experience
Villalba, SR; (...); Ortega, MS
Article. 10.5114/jcb.2021.105280. 2021
Lu-177-DOTATATE therapy in advanced pancreatic neuroendocrine tumors: data from 187 patients of the national registry SEPTRALU
Mitjavila-Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2022
Lung Cancer Symptoms at Diagnosis: Data from the Thoracic Tumors Registry (TTR Study).
Calvo, V; (...); Provencio, M
Meeting Abstract. 2021
Lung cancer symptoms at diagnosis: results of a nationwide registry study.
Ruano-Raviña A; (...); Cerezo S
Article. 10.1136/esmoopen-2020-001021. 2020
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, P; (...); Felip, E
Article. 10.1002/cam4.4135. 2021
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
Kristeleit, Rebecca; (...); Subbiah, Vivek
Article. 10.1007/s10637-023-01383-2. 2023
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.
Longo-Munoz, Federico; (...); Subbiah, Vivek
Article. 10.1016/j.ejca.2022.06.024. 2022
Lutetium177 in patients with stage IV neuroendocrine tumours of any origin. Data from 321 patients of the multicenter national registry
Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.
Meeting Abstract. 2021
Machine Learning-Based Integration of Prognostic Magnetic Resonance Imaging Biomarkers for Myometrial Invasion Stratification in Endometrial Cancer
Rodriguez-Ortega, A; (...); Marti-Bonmati, L
Article. 10.1002/jmri.27625. 2021
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2022
MAIC-10 brief quality checklist for publications using artificial intelligence and medical images.
Cerda-Alberich, Leonor; (...); Marti-Bonmati, Luis
Article. 10.1186/s13244-022-01355-9. 2023
Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community.
Raga, Mireia Gil; (...); Hernandez, Isabel Busquier
Article. 10.1007/s12094-022-03047-8. 2023
Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
Gonzalez-del-Alba, Aranzazu; (...); Climent, Miguel Angel
Article. 10.3390/cancers14051130. 2022
Mapping the scientific research on radiology departments: Global trends in publication, collaboration and trending topics
Cogollos, Lourdes Castello; (...); Marti-Bonmati, Luis
Article. 10.1016/j.ejrad.2021.109841. 2021
Medical imaging clinical trials unit: A professional need.
Penades-Blasco, Ana; (...); Marti-Bonmati, Luis
Article. 10.1016/j.ejrad.2021.110099. 2022
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.
Aparicio J; (...); Fernandez-Montes A
Review. 10.3390/jcm9123889. 2020
Metastatic hormone-sensitive prostate cancer: How should it be treated?
López-Campos F; (...); Couñago F
Article. 10.5306/wjco.v12.i2.43. 2021
Methodological advances in the discovery of novel neuroblastoma therapeutics.
Segura MF; (...); Moreno L
Article. 10.1080/17460441.2022.2002297. 2022
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
Kocak, Burak; (...); Cuocolo, Renato
Article. 10.1186/s13244-023-01572-w. 2024
MLEM Neutron Spectra Unfolding in a Radiotherapy Bunker Using Bonner Sphere Spectrometer
Oliver, S.; (...); Perez-Calatayud, J.
Article. 10.1080/00295639.2023.2192312. 2024
Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.
Conde E; (...); de Álava E
Article. 10.1136/jclinpath-2021-207490. 2021
Molecular Markers and Image Biomarkers. Importance in the Therapeutic Advance of Intraaxial Brain Tumors
Guajardo-Hernandez, U; (...); Zalazar, DR
Article. 2021
Monitoring Bottlenose Dolphin ( Tursiops truncatus) Welfare During a Functional Neuroimaging Study
Ames, Audra E.; (...); Tyack, Peter L.
Article. 10.1578/AM.50.6.2024.495. 2024
Monte Carlo flattening filter design to high energy intraoperative electron beam homogenization
Oliver, S.; (...); Perez-Calatayud, J.
Article. 10.1016/j.radphyschem.2023.111102. 2023
MR Denoising Increases Radiomic Biomarker Precision and Reproducibility in Oncologic Imaging
Fernández Patón M; (...); Martí-Bonmatí L
Article. 10.1007/s10278-021-00512-8. 2021
MRI-based planning in transperineal interstitial brachytherapy for vaginal-involving tumours
Guevara Barrera, Diana; (...); Santos Ortega, Manuel
Meeting Abstract. 2024
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients.
Santaballa, A.; (...); Manau-Trullas, D.
Article. 10.1007/s12094-021-02699-2. 2022
Multi-Institutional Analysis of Metastasis Directed Therapy with or without Androgen Deprivation Therapy in Oligometastatic Castration Sensitive Prostate Cancer.
Sutera, P.; (...); Sweeney, C.
Article. 10.1016/j.ijrobp.2023.06.1620. 2023
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
nab -Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).
Morgensztern D; (...); Ong TJ
Article. 10.3389/fonc.2020.569715. 2021
Nadir PSA in prostate brachytherapy: relationship with biochemical control and clinical results.
Rodriguez Villalba, S.; (...); Santos Ortega, M.
Meeting Abstract. 2023
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Spigel DR; (...); ABOUND.sqm Investigators
Article. 10.1016/j.cllc.2020.09.007. 2021
Necrotizing fasciitis of the thigh secondary to perforated rectal cancer: the sciatic foramen as a route for infective spread
Santarrufina-Martinez, Sandra; (...); Garcia-Granero, Eduardo
Article. 10.24875/CIRU.21000843. 2024
Neutrophil-lymphocyte ratio predicts survival in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD): Stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601
Fidalgo, JAP; (...); Gonzalez-Martin, A
Meeting Abstract. 10.1016/j.annonc.2021.08.1177. 2021
NIRAPARIB AS MAINTENANCE THERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A GEICO STUDY WITHIN THE SPANISH EXTENDED ACCESS PROGRAM
Cueva Banuelos, J. F.; (...); Gonzalez-Martin, A.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.447. 2021
NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Nadal, E.; (...); Bruna, J.
Meeting Abstract. 2022
Nivolumab (NIVO) plus ipilimumab (IPI)+2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA
Reck, M; (...); Paz-Ares, LG
Meeting Abstract. 2020
Nivolumab (NIVO) plus ipilimumab (IPI)+2 Cycles of Platinum-Doublet Chemotherapy (Chemo) vs. 4 Cycles Chemo as First-Line (1L) Treatment) for Stage IV/Recurrent Non-Small Cell Lung Cancer (NSCLC): CheckMate 9LA
Reck, M; (...); Paz-Ares, LG
Meeting Abstract. 2021
Node Oligorecurrence in Prostate Cancer: A Challenge.
Zapatero A; (...); Aldave D
Article. 10.3390/cancers15164159. 2023
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small-Cell Lung Cancer: The Phase II BALTIC Study.
Reinmuth, Niels; (...); Bondarenko, Igor
Article. 10.1158/1078-0432.CCR-24-0013. 2024
Nuclear-medicine probes: Where we are and where we are going
Gonzalez-Montoro A; (...); Javier Gonzalez, Antonio
Article. 10.1002/mp.15690. 2022
Objective Image Quality Comparison Between Brain-Dedicated PET and PET/CT Scanners.
Gandia-Ferrero MT; (...); Martí-Bonmatí L
Article. 10.1007/s10916-023-01984-7. 2023
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Perez-Fidalgo, JA; (...); Gonzalez-Martin, A
Article. 10.1016/j.esmoop.2021.100212. 2021
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V; (...); Zilli T
Article. 10.1016/j.radonc.2022.04.020. 2022
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas, Jesus; (...); Grande, Enrique
Article. 10.1007/s12094-023-03085-w. 2023
Open-source AI-based networks for automatic segmentation of NSCLC on 3D and 4D PET/CT images
Radicioni, Gianluca; (...); Carles, Montserrat
Meeting Abstract. 2024
OReO/ENGOT Ov-38 trial: Impact of maintenance olaparib rechallenge according to ovarian cancer patient prognosis-An exploratory joint analysis of the BRCA and non-BRCA cohorts.
Selle, Frederic; (...); Pujade-Lauraine, Eric
Meeting Abstract. 2022
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
Provencio M; (...); Calvo V
Article. 10.1186/s12885-021-07922-5. 2021
OsimertinibTreatment in Non-Small Cell Lung Cancer (NSCLC) EGFR-T790M+. Activity in Patients with CNS Metastases. OSIREX
Terrasa, J; (...); Provencio, M
Meeting Abstract. 2021
Our experience in Sentinel lymph node biopsy after neoadjuvant chemotherapy treatment
Utrera, A; (...); Vera, V
Meeting Abstract. 2020
Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort.
Lozano-Montoya, Jose; (...); Alberich-Bayarri, Angel
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.10054. 2024
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Martin, Miguel; (...); Gil-Gil, Miguel
Article. 10.1016/j.ejca.2022.03.006. 2022
Pancreatic cancer, Radiomics and Artificial Intelligence: A Review.
Marti-Bonmati L; (...); Alberich-Bayarri A
Article. 10.1259/bjr.20220072. 2022
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D; (...); Marti-Bonmati L
Article. 10.3389/fendo.2023.1213441. 2023
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial
Ost, P.; (...); Zilli, T.
Meeting Abstract. 2022
PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity
Zilli, T.; (...); Ost, P.
Meeting Abstract. 2022
PEACE V-Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial
Zilli, T.; (...); Ost, P.
Meeting Abstract. 2024
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Ost, Piet; (...); Zilli, Thomas
Article. 10.1016/j.euo.2023.09.007. 2023
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Remon J; (...); Besse B
Article. 10.1016/j.cllc.2021.07.008. 2021
Peer review and authorship disclosure.
Editorial Material. 10.1016/j.rxeng.2023.05.004. 2023
Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I
Ponce Aix, S.; (...); Paz-Ares, L.
Meeting Abstract. 10.1016/j.annonc.2021.10.179. 2021
Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.
del Olmo-Garcia, Maria I.; (...); Merino-Torres, Juan F.
Article. 10.3390/cancers14030584. 2022
Peptide receptor radionuclide therapy with [(177)Lu]Lu-DOTA-TATE.
Prado-Wohlwend S; (...); Endocrinology Working Group of the SEMNIM
Article. 10.1016/j.remnie.2021.11.001. 2022
Peptide receptor radionuclide therapy with [Lu-177]Lu-DOTA-TATE
Prado-Wohlwend, S.; (...); SEMNIM
Article. 2022
Pericardial synovial tumor, a rare entity to diagnose by imaging.
Utrera-Costero A; (...); Bernal-Vergara JC
Editorial Material. 10.1016/j.remn.2020.10.005. 2021
Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
Pellino G, García-Granero E, Cervantes A
Letter. 10.1016/j.ejso.2021.06.031. 2021
Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.
Juan Fita, Maria Jose; (...); Heras, Lucia
Meeting Abstract. 2023
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Juan Fita, Maria Jose; (...); Angel Climent, Miguel
Article. 10.3390/cancers15215223. 2023
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
Nadal E; (...); Bruna J
Article. 10.1200/JCO.22.02561. 2023
Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.
Garcia del Muro, Xavier; (...); Vigues, Francesc
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.4505. 2021
Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for progressive disease after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell (mcc) renal cell carcinoma (RCC): Results by independent imaging review and subgroup analyses
Lee, CH; (...); Motzer, RJ
Meeting Abstract. 10.1016/j.annonc.2020.08.782. 2020
Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer
Conde-Moreno, A. J.; (...); Albiach, C. F.
Meeting Abstract. 2021
Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer.
Conde-Moreno AJ; (...); Albiach CF
Article. 10.1016/j.ijrobp.2021.07.151. 2021
Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients
Duran, MAC; (...); Nunez, NF
Meeting Abstract. 10.1016/j.annonc.2020.08.2074. 2020
Plasma mutational burden in PIK3CA and TP53 independently predicts early progression in patients with HR+/HER2-metastatic breast cancer (MBC) enrolled in the GEICAM/2014-12 FLIPPER trial
Gustavo, Federico; (...); Albanell, Joan
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.1029. 2024
Plk1 expression & efficacy of palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03)
Guerrero-Zotano, A; (...); Martin, M
Meeting Abstract. 2021
Portable magnetic resonance imaging of patients indoors, outdoors and at home.
Guallart-Naval, Teresa; (...); Alonso, Joseba
Article. 10.1038/s41598-022-17472-w. 2022
Position of the AI for Health Imaging (AI4HI) network on metadata models for imaging biobanks
Kondylakis, Haridimos; (...); Neri, Emanuele
Article. 10.1186/s41747-022-00281-1. 2022
Precise whole liver automatic segmentation and quantification of PDFF and R2*on MR images
Jimenez-Pastor A; (...); Marti-Bonmati L
Article. 10.1007/s00330-021-07838-5. 2021
Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning.
Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel
Meeting Abstract. 2022
Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning.
Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel
Meeting Abstract. 2022
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model
Ferrer-Lores, Blanca; (...); Alberich-Bayarri, Angel
Article. 10.1186/s13550-024-01172-9. 2024
Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods
Fuster-Matanzo, Almudena; (...); Alberich-Bayarri, Angel
Meeting Abstract. 2024
Predictive Clinical Decision Support System Using Machine Learning and Imaging Biomarkers in Patients With Neurostimulation Therapy: A Pilot Study
De Andres, Jose; (...); Marti-Bonmati, Luis
Article. 2021
Predictive Clinical Decision Support System Using Machine Learning and Imaging Biomarkers in Patients With Neurostimulation Therapy: A Pilot Study.
De Andres J; (...); Marti-Bonmati L
Article. 2021
Predictive value of texture analysis on lumbar MRI in patients with chronic low back pain.
Climent-Peris VJ; (...); Doménech-Fernández J
Article. 10.1007/s00586-023-07936-6. 2023
Preliminary results from PROPEL: A phase I/II study of bempegaldesleukin (BEMPEG: NKTR-214) plus pembrolizumab (PEMBRO) with or without chemotherapy in patients with metastatic NSCLC
Felip, E.; (...); Ganti, A.
Meeting Abstract. 10.1016/j.annonc.2021.10.159. 2021
Pre-plan Technique Benefice in Transperineal Brachytherapy
Guevara Barrera, D.; (...); Santos Ortega, M.
Meeting Abstract. 2023
Prevalence of burnout syndrome during the COVID-19 pandemic and associated factors
Oprisan, A.; (...); Marti-Bonmati, L.
Article. 10.1016/j.rx.2021.09.003. 2022
Prevalence of burnout syndrome in Spanish radiologists
Oprisan, A.; (...); Marti-Bonmati, L.
Article. 10.1016/j.rx.2021.09.001. 2023
Prevalence of burnout syndrome in Spanish radiologists.
Oprisan, A; (...); Marti-Bonmati, L
Article. 10.1016/j.rxeng.2021.09.013. 2023
Profile of Comorbidities and Cancer History in Patients with mNSCLC in the Spanish Population (Thoracic Tumors Registry).
Franco, F; (...); Provencio, M
Meeting Abstract. 2021
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans, Joost L; (...); Laguna, M Pilar
Article. 10.1016/j.euo.2023.10.014. 2023
Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU
Bello, P.; (...); Carmona-Bayonas, A.
Meeting Abstract. 2023
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
Gutierrez, L; (...); Provencio, M
Article. 10.1186/s12885-021-08713-8. 2021
Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.
Girones, Regina, Arnal, Maria, Forcano, Silvia
Meeting Abstract. 2023
Prognostic Value of the Circumferential Resection Margin After Curative Surgery For Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
Galvez, Ana; (...); Kreisler, Esther
Article. 10.1097/DCR.0000000000002294. 2022
PROPEL: A Phase 1/2 Trial of Bempegaldesleukin (NKTR-214) Plus Pembrolizumab in Lung Cancer and other Advanced Solid Tumors
Spigel, DR; (...); Reck, M
Meeting Abstract. 2021
Proposal for standardization of laparoscopic D3 lymphadenectomy for right colon cancer
Garcia-Granero, A.; (...); Gonzalez-Argente, F. X.
Article. 10.1007/s10151-024-02974-8. 2024
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
Jantus-Lewintre, E; (...); Grp Espanol Canc Pulmon GECP
Article. 10.3389/fonc.2021.695038. 2021
Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines.
Rivero-Buceta, Eva; (...); Botella, Pablo
Article. 10.1016/j.ijpharm.2024.124623. 2024
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
Cosenza-Contreras, Miguel; (...); Schilling, Oliver
Article. 10.1093/neuonc/noad208. 2023
PRRT of 200 patients from the SEPTRALU registry: real-world data
Casanovas, MM; (...); Jimenez-Fonseca, P
Meeting Abstract. 2020
PSA outcomes after LDR/HDR brachytherapy in LR and IR prostate cancer: a predictor of response
Rodriguez Villalba, Silvia; (...); Santos Ortega, Manuel
Meeting Abstract. 2024
Publishing in open access journals.
Quaia, Emilio; (...); Marti-Bonmati, Luis
Editorial Material. 10.1186/s13244-024-01794-6. 2024
Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
Tibau, A; (...); Albanell, J
Meeting Abstract. 10.1016/j.annonc.2021.03.108. 2021
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Tibau, Ariadna; (...); Albanell, Joan
Article. 10.1177/17588359221148921. 2023
Quantification of H(2)(17)O by (1)H-MR imaging at 3 T: a feasibility study.
Martí-Bonmatí L; (...); Ferrer E
Article. 10.1186/s41747-021-00246-w. 2021
Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR
Reeder, Scott B.; (...); Marti-Bonmati, Luis
Review. 10.1148/radiol.221856. 2023
Quantitative evaluation of a non-CT based attenuation correction method for a new dedicated brain PET
Gandia-Ferrero, M.; (...); Marti-Bonmati, L.
Meeting Abstract. 2022
Quantitative Evaluation of Neonatal Brain Elasticity Using Shear Wave Elastography.
Garcés Iñigo E; (...); Martí-Bonmatí L
Article. 10.1002/jum.15464. 2020
Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice
Bargiela, Ariadna; (...); Artero, Ruben
Article. 10.1038/s41598-023-27661-w. 2023
Radio theranostics in paragangliomas and pheochromocytomas
Wohlwend, S. Prado, Arques, P. Bello
Article. 10.1016/j.remn.2024.500017. 2024
Radio theranostics in paragangliomas and pheochromocytomas.
Wohlwend SP, Arques PB
Article. 10.1016/j.remnie.2024.500017. 2024
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Oliván-Sasot P; (...); Olivas-Arroyo C
Article. 10.1016/j.rx.2020.09.012. 2020
Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.
Olivan-Sasot, P; (...); Olivas-Arroyo, C
Article. 10.1016/j.rxeng.2021.03.001. 2023
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer.
Edelman, Martin J.; (...); DISTINCT Study Investigators
Article. 10.1016/j.lungcan.2022.03.003. 2022
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
Albanell, J.; (...); Rojo, F.
Article. 10.1016/j.ejca.2021.11.010. 2022
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
Aparicio, Jorge; (...); Maurel, Joan
Article. 10.1007/s12094-022-02868-x. 2022
Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01)
Aparicio, J; (...); Maurel, J
Meeting Abstract. 10.1016/j.annonc.2021.08.937. 2021
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Harter P; (...); du Bois A
Article. 10.1056/NEJMoa2103294. 2021
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.
Longo F; (...); Díaz-Cerezo S
Article. 10.2217/fon-2020-1216. 2021
Real-time fluorescence image-guided gastrointestinal oncologic surgery: Towards a new era
Martinez-Lopez, Elias; (...); Garcia-Granero, Eduardo
Review. 10.4251/wjgo.v13.i9.1029. 2021
Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)
Redondo, Andres; (...); Gonzalez-Martin, Antonio
Article. 10.31083/j.ejgo4206163. 2021
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study.
López Muñoz AM; (...); Martín Gómez T
Article. 10.1007/s12094-024-03630-1. 2024
Real-world evidence analysis of early-stage prostate cancer using natural language processing
Juarez, Alvaro; (...); Alcaraz, Antonio
Meeting Abstract. 2023
Real-world outcomes of first-line pembrolizumab (Pem) for metastatic non-small cell lung cancer (mNSCLC) with >= 50% expression of programmed cell death-ligand 1 (PD-L1): A multicentre retrospective study
Perea, J.; (...); Gaudens, P. Capdevila
Meeting Abstract. 2023
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Cueva, Juan F.; (...); Gonzalez-Martin, Antonio
Article. 10.1016/j.ejca.2022.12.023. 2022
Recent treatment advances in clinical stage i nonseminomatous germ cell tumors.
Letter. 10.1016/j.acuro.2020.08.014. 2021
Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM.
Conde-Moreno AJ; (...); Contreras Martínez J
Article. 10.1007/s12094-020-02540-2. 2021
Rectal cancer at the peritoneal reflection. Preoperative MRI accuracy and histophatologic correlation. Prospective study.
Álvarez Sarrado E; (...); Garcia-Granero Ximénez E
Article. 10.1016/j.ciresp.2021.04.009. 2021
Rectal cancer at the peritoneal reflection. Preoperative MRI accuracy and histophatologic correlation. Prospective study.
Álvarez Sarrado E; (...); Garcia-Granero Ximénez E
Article. 10.1016/j.cireng.2022.05.019. 2022
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.
Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis
Article. 10.1016/j.bbr.2023.114844. 2024
Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma Tumors.
Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis
Article. 10.1148/ryai.230208. 2024
RESILIENT part 1: A phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer.
Paz-Ares, Luis; (...); Bunn, Paul A.
Article. 10.1002/cncr.34123. 2022
RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)
Ponce, S; (...); Bunn, PA
Meeting Abstract. 10.1016/j.annonc.2020.08.1554. 2020
RESILIENT Part 1: Safety and Efficacy of Second-Line Liposomal Irinotecan in Patients with Small Cell Lung Cancer
Paz-Ares, L; (...); Bunn, P
Meeting Abstract. 2021
RESILIENT Part 2: A phase 3 Study of Liposomal Irinotecan in Patients with Small-Cell Lung Cancer in the Second-Line Setting
Paz-Ares, L; (...); Bunn, P
Meeting Abstract. 2021
Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.
Prado-Wohlwend, Stefan; (...); Merino-Torres JF
Article. 10.3389/fendo.2022.957172. 2022
RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
Conde, E.; (...); Lopez-Rios, F.
Meeting Abstract. 2021
RET Fusion Testing in Patients With NSCLC: The RETING Study.
Conde, Esther; (...); Lopez-Rios, Fernando
Article. 10.1016/j.jtocrr.2024.100653. 2024
RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
Hernandez, S.; (...); Conde, E.
Meeting Abstract. 2022
Retrospective real-world data study using natural language processing to describe treatment sequence and clinicopathological patterns in patients with metastatic colorectal cancer in five Spanish institutions
Vera Garcia, R.; (...); Mondejar Solis, R.
Meeting Abstract. 10.1016/j.annonc.2023.04.343. 2023
Review on Treatment Planning Systems for Cervix Brachytherapy (Interventional Radiotherapy): Some Desirable and Convenient Practical Aspects to Be Implemented from Radiation Oncologist and Medical Physics Perspectives.
Otal, Antonio; (...); Perez-Calatayud, Jose
Article. 10.3390/cancers14143467. 2022
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohort.
Lozano-Montoya, Jose; (...); Alberich-Bayarri, Angel
Article. 10.3389/fonc.2025.1528836. 2025
Robotic transanal total mesorectal excision: Is the future now?
Sebastian-Tomas, JC; (...); Garcia-Granero, E
Review. 10.4240/wjgs.v13.i8.834. 2021
Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis
Isabel Moreno-Gambin, Maria; (...); Vázquez-Costa JF
Article. 10.1007/s00415-021-10729-w. 2021
Role of the receptor for advanced glycation end products (RAGE) in blood as a potential biomarker for progression to olaparib: A post hoc analysis of patients with platinum-resistant ovarian cancer (PROC) treated in the ROLANDO-GEICO 1601 trial
Perez-Fidalgo, Jose Alejandro; (...); Gonzalez-Martin, Antonio
Meeting Abstract. 2024
RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II
Alvarez, A.; (...); Marquez Rodas, I.
Meeting Abstract. 2023
Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.
Yubero, Alfonso; (...); Gonzalez-Martin, Antonio
Case Reports. 10.1016/j.gore.2023.101211. 2023
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study
Yubero, Alfonso; (...); Gonzalez-Martin, Antonio
Article. 10.1186/s12885-022-10191-5. 2022
Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and PD(L)-1inhibitors (IO): Primary results from the phase 3 EVOKE-01 study.
Paz-Ares, Luis G.; (...); Garassino, Marina Chiara
Meeting Abstract. 10.1200/JCO.2024.42.17_suppl.LBA8500. 2024
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.
Paz-Ares, Luis G.; (...); Garassino, Marina Chiara
Article. 10.1200/JCO.24.00733. 2024
Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
Vaz, Maria Angeles; (...); Martinez-Garcia, Maria
Meeting Abstract. 2022
Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)
Ost, Piet; (...); Moon, Daniel
Meeting Abstract. 2024
Same-day comparative protocol PET/CT-PET/MRI [68Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.
Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco
Article. 10.1186/s40644-023-00521-6. 2023
Second-Line Nivolumab in Relapsed Small-Cell Lung Cancer: CheckMate 331.
Spigel DR; (...); Reck M
Article. 10.1016/j.annonc.2021.01.071. 2021
Second-line treatment in advanced non-squamous (NS) non-small cell lung cancer (NSCLC) patients in Spain, analyzed in the Thoracic Tumor Registry (RTT)
Carcereny Costa, E.; (...); Provencio Pulla, M.
Meeting Abstract. 10.1016/j.annonc.2022.02.062. 2022
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD; (...); Veronesi P
Article. 10.1001/jamaoncol.2023.3759. 2023
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
Garcia-Campelo, Rosario; (...); Domine, Manuel
Article. 10.1007/s12094-023-03216-3. 2023
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Barretina-Ginesta MP; (...); Rubio-Pérez MJ
Article. 10.1007/s12094-022-02799-7. 2022
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).
Martínez-García M; (...); Manuel Sepúlveda-Sánchez J
Article. 10.1007/s12094-022-02803-0. 2022
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura, Pedro Perez; (...); Losada, Estela Pineda
Article. 10.1007/s12094-023-03245-y. 2023
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
Fernandez Montes, Ana; (...); Aparicio, Jorge
Article. 10.1007/s12094-023-03199-1. 2023
SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).
Arranz Arija, Jose Angel; (...); Gonzalez-Billalabeitia, Enrique
Article. 10.1007/s12094-024-03532-2. 2024
SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain.
Perez-Calatayud MJ; (...); Perez-Calatayud J
Article. 10.1007/s12094-021-02583-z. 2021
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis.
Lopez-Campos, F.; (...); Conde-Moreno, A.
Article. 10.1007/s12094-021-02695-6. 2022
SEPTRALU registry of 177-Lu-DOTATATE in neuroendocrine tumors: Data from 321 patients in clinical practice
Casanovas, MM; (...); Carmona-Bayonas, A
Meeting Abstract. 2021
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.
Valladares-Ayerbes M; (...); Lloansí Vila A
Article. 10.1007/s12094-024-03487-4. 2024
Sequential treatment of High-risk Neuroblastoma combining I-131 MIBG high-dose and Topotecan. First experience
Orrego, N.; (...); Bello-Arques, P.
Meeting Abstract. 2023
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study.
Provencio, Mariano; (...); Cobo, Manuel
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.8531. 2021
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Provencio, Mariano; (...); Cobo, Manuel
Article. 10.21037/tlcr-21-504. 2022
Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.
Vera, Ruth; (...); del Alba, Aranzazu Gonzalez
Article. 10.1007/s12094-023-03112-w. 2023
Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis
Suay, Guillermo; (...); Juan-Vidal, Oscar
Review. 10.3390/cancers15184433. 2023
Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.
Garcia-Dominguez, Ximo; (...); Marco-Jimenez, Francisco
Article. 10.3390/jcm11113068. 2022
SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer.
Russo, Chiara; (...); Battisti NML
Article. 10.1016/j.jgo.2023.101564. 2023
Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
Carcereny Costa, E.; (...); Provencio Pulla, M.
Meeting Abstract. 10.1016/j.annonc.2020.08.1547. 2020
Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement
Perez Calatayud, M. J.; (...); Tormo, A.
Meeting Abstract. 2020
SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain.
Juan Fita, Maria Jose; (...); Molina Diaz, Aurea
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.e1656. 2024
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.
Del Olmo-Garcia MI; (...); Merino-Torres JF
Article. 10.3390/biomedicines9121810. 2021
Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates
Vijande, J; (...); Perez-Calatayud, J
Article. 10.1016/j.phro.2021.07.007. 2021
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.
Peressini M; (...); Zugazagoitia J
Article. 10.1158/1078-0432.CCR-24-0104. 2024
Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
Baviera-Munoz, Raquel; (...); Bataller, Luis
Article. 10.1002/mdc3.13740. 2023
State of the scientific evidence and recommendations for the management of older patients with gastric cancer.
Paredero-Perez, Irene; (...); Girones-Sarrio, Regina
Article. 10.1016/j.jgo.2023.101657. 2023
Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study.
Mielgo-Rubio X; (...); Couñago F
Editorial Material. 10.5306/wjco.v11.i12.983. 2020
Studies performed for the characterization of a mailed dosimetric audit of HDR Brachytherapy
Canamas, L. Oliver; (...); Perez-Calatayud, J.
Meeting Abstract. 2023
Supervised Domain Adaptation for Automated Semantic Segmentation of the Atrial Cavity
Saiz-Vivo, Marta; (...); Naranjo, Valery
Article. 10.3390/e23070898. 2021
Surgical repair of parastomal bulging: a retrospective register-based study on prospectively collected data
Sancho-Muriel, J; (...); Frasson, M
Article. 10.1111/codi.15197. 2020
Survival outcomes in ALK-positive NSCLC patients (p) treated 1st line brigatinib and impact of the ALK fusion variant
Provencio-Pulla, Mariano; (...); Romero, Atocha
Meeting Abstract. 2023
Survival, quality of life (QoL) and geriatric outcomes of elderly patients (pt) with advanced non-small cell lung cancer (NSCLC), treated with pembrolizumab (P) in the first-line setting
Blanco, R; (...); Vidal, OJJ
Meeting Abstract. 10.1016/j.annonc.2020.08.1631. 2020
Synergies Among Health Data Projects with Cancer Use Cases Based on Health Standards.
Gyrard, Amelie; (...); Alvarez, Eva Garcia
Article. 10.3233/SHTI240649. 2024
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ; (...); Paz-Ares L
Article. 10.1056/NEJMoa2307980. 2023
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/ijms23158526. 2022
The Authors Reply.
Garcia-Granero A; (...); Garcia-Granero E
Letter. 10.1097/DCR.0000000000001771. 2020
The contribution of brain volume to explain autonomous imbalance during recovery from acute stress in batterers.
Romero-Martinez, Angel; (...); Moya-Albiol, Luis
Letter. 10.1007/s00429-024-02772-w. 2024
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T; (...); Ost P
Editorial Material. 10.1016/j.euf.2020.12.010. 2021
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer.
Sancho-Muriel, Jorge; (...); Frasson, Matteo
Article. 10.1111/codi.16522. 2023
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
Seidel C; (...); Oing C
Article. 10.1007/s00345-021-03635-3. 2021
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Pizarro, David; (...); Palacios, Jose
Article. 10.3390/ijms241311183. 2023
The radiology report: structure, style, and contents
Marti-Bonmati, L., Alberich-Bayarri, A., Torregrosa, A.
Article. 10.1016/j.rx.2022.01.013. 2022
The Role of Imaging Studies in Favor of Possible Cerebellar Multiple System Atrophy: A Case Study.
Utrera-Costero, Ana; (...); Bello-Arques, Pilar
Article. 10.1097/RLU.0000000000003767. 2021
The role of intimate partner violence perpetrators' resting state functional connectivity in treatment compliance and recidivism.
Romero-Martinez, Angel; (...); Moya-Albiol, Luis
Article. 10.1038/s41598-024-52443-3. 2024
The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?
Perez-Ardavin J; (...); Vera-Donoso CD
Article. 10.23736/S1824-4785.22.03416-1. 2022
The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer.
Mislang AR; (...); Battisti NML
Letter. 10.1016/j.jgo.2021.03.003. 2021
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Gomez Rueda, Ana; (...); Garrido, Pilar
Article. 10.1007/s12094-024-03404-9. 2024
The value of F-18-FDG PET/CT in two cases of Primary Pericardial Mesothelioma
Utrera-Costero, Ana; (...); Bello-Arques, Pilar
Article. 10.1007/s12350-021-02690-y. 2021
Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion.
Ramirez-Carracedo, Rafael; (...); Zaragoza, Carlos
Article. 10.1161/CIRCIMAGING.121.013379. 2022
Thoracic Tumors Registry (RTT): Analysis of Clinical Features and Survival in Patients with mNSCLC in Spain.
Franco, F; (...); Provencio, M
Meeting Abstract. 2021
To the editor, response letter.
Conde-Moreno AJ; (...); Contreras J
Letter. 10.1007/s12094-021-02641-6. 2021
Transforming experimental radiology: Design and implementation of an innovative ePACS image storage system for AI imaging research environments.
Gomez-Rico Junquero, Ignacio; (...); Marti-Bonmati, Luis
Article. 10.1016/j.ijmedinf.2024.105549. 2024
Translating radiological research into practice-from discovery to clinical impact
Smits, Marion; (...); Marti-Bonmati, Luis
Article. 10.1186/s13244-023-01596-2. 2024
Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer
Palanca-Ballester, Cora; (...); Sandoval, Juan
Article. 10.1186/s13148-022-01334-3. 2022
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity.
López-Campos F; (...); Hervás Morón A
Article. 10.3390/jpm11111190. 2021
Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensus.
Isla D; (...); Juan-Vidal O
Article. 10.1007/s12094-020-02518-0. 2021
Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
Article. 10.1016/j.ygyno.2021.03.001. 2021
Undertreatment and overtreatment in older patients treated with chemotherapy.
Feliu J; (...); Molina-Garrido MJ
Article. 10.1016/j.jgo.2020.10.010. 2020
Update on iodine-refractory differentiated thyroid carcinoma
Casas, E. Abou Jokh; (...); Casas, J. A. Vallejo
Article. 10.1016/j.remn.2023.06.005. 2023
Update on iodine-refractory differentiated thyroid carcinoma.
Jokh Casas, E A; (...); Vallejo Casas, J A
Article. 10.1016/j.remnie.2023.07.003. 2023
Update on the management of elderly patients with colorectal cancer.
Soler-Gonzalez, Gemma; (...); Girones-Sarrio, Regina
Article. 10.1007/s12094-023-03243-0. 2023
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
Guillot Morales M; (...); Gironés Sarrió R
Article. 10.1007/s12094-024-03386-8. 2024
Updated analysis from the ATEZO-BRAIN trial: Atezolizumab plus carboplatin and pemetrexed in patients with advanced nonsquamous non-small cell lung cancer with untreated brain metastases.
Nadal, Ernest; (...); Bruna, Jordi
Meeting Abstract. 2022
Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.
Soto-Perez-de-Celis, Enrique; (...); Battisti, Nicolo Matteo Luca
Article. 10.1016/j.jgo.2022.07.005. 2022
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial
Albanell, Joan; (...); Rojo Todo, Federico Gustavo
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.1028. 2024
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report.
Simarro J; (...); Palanca S
Article. 10.3390/diagnostics12051266. 2022
Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.
Lopez-Vilella, R; (...); Bonet, LA
Article. 10.1016/j.transproceed.2021.07.058. 2021
Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II
Prat-Acin, Ricardo; (...); Vera-Sempere, Francisco
Article. 10.1016/j.jocn.2021.01.009. 2021
Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients
Munoz Martin, A.; (...); Angel Hernandez-Presa, M.
Meeting Abstract. 2022
Virtual conferences: results of an international survey on radiologist preferences and perspectives
D'Anna, Gennaro; (...); Ranschaert, Erik
Article. 10.1007/s00330-022-08903-3. 2022
What do biomarkers add: Mapping quantitative imaging biomarkers research.
Meseguer E; (...); Martí-Bonmatí L
Article. 10.1016/j.ejrad.2021.110052. 2022
WP21 BRAPHYQS survey of differences in 192Ir and 60Co brachytherapy RAKR determinations
Vijande, J; (...); Perez-Calatayud, J
Meeting Abstract. 2021
Y-90 PET/MR imaging optimization with a Bayesian penalized likelihood reconstruction algorithm.
Calatayud-Jordan, Jose; (...); Torres-Espallardo, Irene
Article. 10.1007/s13246-024-01452-7. 2024